A look at Gilead Sciences Inc. — The bulls continue to run.

print
Gilead Sciences Inc. ($GILD) averages are at $78.63 (21 day SMA), $75.68 (50 day SMA), $63.67 (200 day SMA). Over the past 52 weeks GILD has traded from a low of $40.16 to a high of $84.40. GILD was last at $80.44 on a volume of 4,541,700. Average daily volume has been at 11,675,330.

52 Week Range $40.16-$84.40
Market Cap 123,549,604,216
Average Volume 11,675,330
Dividend Yield 0.00%
Institutional Ownership 96.60%
Insider Ownership: 1.00%
Percentage of Float Short 5.50%
Beta 0.56

Gilead (GILD) has been bouncing along the 50-day moving average since July of 2012. This has been a very reliable technical support level that currently stands at $75.80. The steady uptrend remains intact after a successful test of that key moving average on Friday, February 7th. The stock is currently at $80.35 — just 6% above support. If you trade using chart analysis for a long-term bullish position, a stop that’s above 8% below current stock price levels would generate a prudent risk/reward profile.

Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes new medicines for different medical sectors.

Articles

Leave a Comment